Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues

Thérese Cronin1, Thierry Léveillard, José-Alain Sahel

  • 1Laboratoire de physiopathologie cellulaire et moleculaire de la retine, unite 592 Inserm-universite Pierre-et-Marie-Curie, France.

Current Gene Therapy
|April 14, 2007
PubMed

Insights

Extracellular signals drive retinal degeneration (RD). Understanding these non-cell-autonomous mechanisms offers new therapeutic targets for blindness caused by retinal dystrophies.

Area of Science:

  • Ophthalmology and Molecular Biology

Background:

  • Retinal degeneration (RD) involves complex extracellular signaling.
  • Gene regulation is crucial for retinal structure and function.

Purpose of the Study:

  • Review non-cell-autonomous mechanisms in retinal dystrophies.
  • Identify signaling molecules influencing degeneration.
  • Explore therapeutic prospects for blindness.

Main Methods:

  • Literature review of studies on retinal degeneration.
  • Analysis of extracellular signaling pathways.
  • Evaluation of gene regulatory events in retinal diseases.

Main Results:

  • Non-cell-autonomous mechanisms significantly impact RD patterns.
  • Specific signaling molecules modulate disease progression.
  • Therapeutic strategies targeting these signals show promise.

Conclusions:

  • Extracellular signaling is a key factor in retinal degeneration.
  • Targeting these pathways presents viable therapeutic opportunities for retinal dystrophies.
  • Further research can advance treatments for blindness.